Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: The investigation of peripheral mechanisms

Neuropeptides

Volumn 41, Issue 6, 2007, Pages 465-475

  Yalcin, Murat ^a   Savci, Vahide ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Brain phospholipase A2 (PLA2); Catecholamine; Heart rate (HR); Hemorrhagic shock; Intracerebroventricular; Mean arterial pressure (MAP); Melittin; Renin activity; Vasopressin

Indexed keywords

ADRENALIN; MELITTIN; NORADRENALIN; PRAZOSIN; RENIN; SARALASIN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; HEART RATE; HEMORRHAGIC HYPOTENSION; HEMORRHAGIC SHOCK; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; EPINEPHRINE; HEMORRHAGE; HYPOTENSION; MALE; MELITTEN; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VASOPRESSINS;

ANIMALIA; RATTUS;

EID: 36048958517     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.07.002     Document Type: Article

References (33)

1. 2: perspective on the history. Prostagl. Leukotr. Essent. Fatty Acids 71 (2004) 161-169
2. Ariumi H., Takano Y., Masumi A., Takahashi S., Hirabara Y., Honda K., Saito R., and Kamiya H. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats. Neurosci. Lett. 324 (2002) 61-64
3. Brooks D.P., Share L., Crofton J.T., and Nasjletti A. Central indomethacin enhances volume-dependent vasopressin release. Am. J. Physiol. 247 (1984) R1017-R1021
4. Brooks D.P., Share L., and Crofton J.T. Role of brain prostaglandins in the control of vasopressin secretion in the conscious rat. Endocrinology 118 (1986) 1716-1722
5. Chemtob S., Beharry K., Rex J., Varma D.R., and Aranda J.V. Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure. Circ. Res. 67 (1990) 674-682
6. Chisari A., Spinedi E., Voirol M.J., Giovambattista A., and Gaillard R.C. A phospholipase A2-related snake venom (from Crotalus durissus terrificus) stimulates neuroendocrine and immune functions: determination of different sites of action. Endocrinology 139 (1998) 617-625
7. Hassid A., and Levine L. Stimulation of phospholipase activity and prostaglandin biosynthesis by melittin in cell culture and in vivo. Res. Commun. Chem. Pathol. Pharmacol. 18 (1977) 507-517
8. Kong D.L., Prough D.S., Whitley J.M., Taylor C., Vines S., Deal D.D., and DeWitt D.S. Hemorrhage and intracranial hypertension in combination in cerebral production of thromboxane A2. Crit. Care Med. 19 (1991) 532-538
9. 2 in the activation of the central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 452 (2002) 289-294
10. 2 with azobenzene-containing phospholipids. J. Biochem. 109 (1991) 383-388
11. Phillis J.W., and O'Regan M.H. The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit. Rev. Neurobiol. 15 (2003) 61-90
12. Savci V., Cavun S., Gurun M.S., and Ulus I.H. Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine. Pharmacology 62 (2001) 36-44
13. Savci V., Cavun S., Goktalay G., and Ulus I.H. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Naunyn-Schmiedeberg's Arch. Pharmacology 365 (2002) 388-398
14. Savci V., Goktalay G., Cansev M., Cavun S., Yilmaz M.S., and Ulus I.H. Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur. J. Pharmacol. 468 (2003) 129-139
15. Siren A.L. Central cardiovascular and thermal effects of prostaglandin E2 in rats. Acta Physiol. Scand. 116 (1982) 229-234
16. Siren A.L. Central cardiovascular and thermal effects of prostaglandin D2 in rats. Prostagl. Leukotr. Med. 8 (1982) 349-359
17. Siren A.L. Differences in the central actions of arachidonic acid and prostaglandin F2 alpha between spontaneously hypertensive and normotensive rats. Life Sci. 30 (1982) 503-513
18. Sirko S., Bishai I., and Coceani F. Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. Am. J. Physiol. 256 (1989) R616-R624
19. Tong H., Lakhdir F., and Wood C.E. Endogenous prostonoids modulate the ACTH and AVP responses to hypotension in late gestation fetal sheep. Am. J. Physiol. 275 (1998) R735-R741
20. Wagner C., Jensen B.L., Kramer B.K., and Kurtz A. Control of the renal renin system by local factors. Kidney Int. Suppl. 67 (1998) S78-S83
21. Wilcoxs C.S., Gao H., Verbalis J.G., and Welch W.J. Role of AVP in pressor responses during activation of central TXA2/PGH2 receptors. Am. J. Physiol. 273 (1997) H1927-H1932
22. Yalcin M., and Savci V. Restoration of blood pressure by centrally injected U-46619, a thromboxane A2 analog, in haemorrhaged hypotensive rats: investigation of different brain areas. Pharmacology 70 (2004) 177-187
23. Yalcin M., Cavun S., Yilmaz M.S., and Savci V. The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2005) 31-40
24. 2 in hypotension induced by haemorrhage in rats. Clin. Exp. Pharmcol. Physiol. 32 (2005) 960-967
25. Yalcin M., Ak F., and Erturk M. The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats. Neuropeptides 40 (2006) 207-212
26. Yalcin M., Cavun S., Yilmaz M.S., and Savci V. Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats. Brain Res. 1118 (2006) 43-51
27. Yalcin M., and Erturk M. The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats. Neuropeptides 40 (2007) 103-110
28. Yamaguchi G., Hama H., and Watanabe K. Possible participation of prostaglandins generated in the anteroventral third ventricular region in the hypovolemia-induced vasopressin secretion of conscious rats. Eur. J. Endocrinol. 138 (1998) 206-215
29. Yamamoto M., Share L., and Shade R.E. Effect of ventriculocisternal perfusion with angiotensin II and indomethacin on vasopressin concentration. Neuroendocrinology 25 (1978) 166-173
30. Yokotani K., Okuma Y., and Osumi Y. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 279 (1995) 233-239
31. Yokotani K., Wang M., Murakami Y., Okada S., and Hirata M. Brain phospholipase A2-arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 398 (2000) 341-347
32. Yokotani K., Murakami Y., Okada S., and Hirata M. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 419 (2001) 183-189
33. Zhang Z.H., Wei S.G., Francis J., and Felder R.B. Cardiovascular and renal sympathetic activation by blood-borne TNF-α in rat: the role of central prostaglandins. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R916-R927